Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in thrombolytic therapy.

M Verstraete1

  • 1Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

Cardiovascular Drugs and Therapy
|April 1, 1992
PubMed
Summary

New thrombolytic drugs offer improved fibrin specificity over older agents, with ongoing research into targeted therapies and antithrombotic combinations to enhance treatment efficacy and prevent reocclusion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influencing factors in knee kinematics following posteriorly stabilized knee arthroplasty: a comprehensive analysis.

Acta orthopaedica Belgica·2025
Same author

Trends For Smaller Medical Journals.

Acta clinica Belgica·2016
Same author

Temperature dependence of the electronic structure of semiconductors and insulators.

The Journal of chemical physics·2015
Same author

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

British journal of cancer·2015
Same author

[Update on the management of acute viral bronchiolitis: proposed guidelines of Grand Ouest University Hospitals].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013
Same author

[Management of bronchiolitis in general practice and determinants of treatment being discordant with guidelines of the HAS].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013

Area of Science:

  • Cardiovascular pharmacology
  • Thrombosis and hemostasis

Background:

  • First-generation thrombolytic drugs like streptokinase and urokinase have limitations.
  • Alteplase and saruplase exhibit greater fibrin specificity than anistreplase.
  • Evolving administration methods include bolus injections and accelerated infusions.

Purpose of the Study:

  • To review advancements in thrombolytic drug development.
  • To discuss strategies for improving thrombolytic therapy and preventing reocclusion.
  • To highlight ongoing investigations into novel therapeutic agents.

Main Methods:

  • Review of existing literature on thrombolytic and antithrombotic agents.
  • Analysis of molecular modifications and targeted drug delivery systems.
  • Examination of clinical investigations for new antithrombotic and prostacyclin analogues.

Main Results:

  • Truncated and hybrid molecules of alteplase/saruplase have not improved potency.
  • Recombinant staphylokinase and bat saliva plasminogen activator show promise.
  • Thrombus-targeted agents and novel antithrombotics are under investigation.

Conclusions:

  • Fibrin-specific thrombolytics necessitate co-administration with antithrombotic drugs.
  • The superiority of new anticoagulants and antiplatelet agents over heparin and aspirin is under clinical evaluation.
  • The role of prostacyclin analogues in thrombolytic treatment remains undetermined.

Related Experiment Videos